Stock Analysts' Downgrades for August 1st (APLS, BRO, CLAR,

Stock Analysts’ downgrades for Tuesday, August 1st: Apellis Pharmaceuticals (NASDAQ:APLS) was downgraded by analysts at Bank of America Co. from a buy rating to a neutral rating. Bank of America Co. currently has $40.00 price target on the stock, down from their previous price target of $114.00. Brown & Brown (NYSE:BRO) was downgraded by analysts […]

Related Keywords

United States , Canada , America , Canadian , Piper Sandler , Stifel Nicolaus , Robertw Baird , William Blair , Raymond James , Citigroup Inc , Wells Fargo Company , Reata Pharmaceuticals , Topaz Energy , Telia Company , Berenberg Bank , Deutsche Bank Aktiengesellschaft , Hovde Group , Valley National Bancorp , Domino Pizza Group , News Ratings For Apellis Pharmaceuticals Inc Daily , Apellis Pharmaceuticals , Cantor Fitzgerald , Credit Suisse Group , National Bank Financial , Barclays Plc , Lauder Companies , Canadian National Railway , America Co , Insteel Industries , Apellis Pharmaceuticals Inc , Stock Analyst , National Railway , Pizza Group , Peel Hunt , Kepler Capital Markets , Wells Fargo , Loop Capital , Suisse Group , Crest Metals , National Bancorp , Info Technologies , Apellis Pharmaceuticals Inc Daily , Brown Inc , Clarus Co , Dominos Pizza Group Plc , The Estée Lauder Companies Inc , Eastman Chemical , Flowers Foods Inc , Technipfmc Plc , Herbalife Ltd ,